bioRxiv ScienceSearch

bioRxiv · 10.1101/573006

Analytic Model of fMRI BOLD Signals for Separable Metrics of Neural and Metabolic Activity

Abstract

The applications of fMRI (functional magnetic resonance imaging) are broad covering diagnostic and clinical extents of brain function, which involves the analysis of BOLD (blood oxygen level-dependent) contrast signals. The BOLD signals are sourced from both neural and metabolic functions, and thus to enable a detailed examination of fMRI studies, methods are sought to separate the neural and metabolic functions, such that the neural component, which is often the metric of interest, can be independently examined, especially in relation to neural connectivity. In this work, a modeling approach is developed that separates the neural and metabolic functions from the overall BOLD signal. The newly developed model is initially developed within a linear framework and demonstrates excellent comparison in data fit at 97.4% to the three Gamma function, which has been widely used to characterize fMRI BOLD experimental data. The neural component of the model formulation is comprised of a proper transfer function of two poles and two zeros, and characterizes the salient features of the BOLD signal, including the initial dip, peak, undershoot, and stabilization period. The linear model is extended to characterize nonlinear fMRI BOLD signal responses through the integration of saturation functions to both the leading and trailing edges of the signal. The nonlinear model representation not only explains the muted response in amplitude and oscillations, but also explains nuanced oscillations during the hold and settling phases of fMRI BOLD responses as exemplified in comparison to published data of sensorimotor responses. Further, the newly developed decomposition is derived within a framework for modeling neurovascular coupling environments, and thus lends credibility to the modeling framework. In developing the decomposition of the neural and metabolic transfer functions, it is a conclusion that the BOLD signal correlates very well with the fast dynamics associated with neural response to external stimuli.\n\nGraphical Abstract\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=155 SRC=\"FIGDIR/small/573006_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (17K):\norg.highwire.dtl.DTLVardef@1171945org.highwire.dtl.DTLVardef@17c3c0aorg.highwire.dtl.DTLVardef@149eebborg.highwire.dtl.DTLVardef@d840e1_HPS_FORMAT_FIGEXP M_FIG C_FIG The normalized impulse response of the BOLD signal and the corresponding neural activity according to the newly developed model. There is a correspondence of the critical points for the oscillatory response of the neural function and metabolic reactivity, including the initial dip, peak and subsequent undershoot. Thus, the BOLD signal is a correlated representation of the underlying neural response.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Schaper, C.. 2019-03-09. Analytic Model of fMRI BOLD Signals for Separable Metrics of Neural and Metabolic Activity. https://doi.org/10.1101/573006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience